Benefit of extending the dosing interval of long-acting injection in maintenance treatment of outpatients with schizophrenia

Asian J Psychiatr. 2020 Feb:48:101900. doi: 10.1016/j.ajp.2019.101900. Epub 2019 Dec 9.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino², Atsuhiko Takaya², Yuichi Inoue³

Affiliations

¹ Department of Psychiatry, Suzuki Clinic, Tokyo, 168-0065, Japan. Electronic address: suzuhiromarket@yahoo.co.jp.
² Department of Psychiatry, Fukui Kinen Hospital, Kanagawa, 238-0115, Japan.
³ Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo, 116-0011, Japan.

PMID: 31896439
DOI: 10.1016/j.ajp.2019.101900

No abstract available

Publication types

Letter

MeSH terms

Adult
Antipsychotic Agents / administration & dosage*
Delayed-Action Preparations
Drug Administration Schedule
Female
Humans
Injections
Male
Middle Aged
Outcome Assessment, Health Care*
Outpatients
Retrospective Studies
Schizophrenia / drug therapy*
Schizophrenia / prevention & control
Secondary Prevention*

Substances

Antipsychotic Agents
Delayed-Action Preparations